top of page

Does Your PRP Spine Doctor Treat the Entire Spine? Why Experience, Anatomy, and Injection Precision Matter

Deborah Westergaard, M.D.
5 days ago
10 min read

By Deborah Westergaard, M.D. | Double Board-Certified in Anesthesiology and Pain Medicine



If you're considering PRP injections for neck or back pain, there is an important question to ask before selecting a physician:

Does your physician have the training and experience to evaluate and treat the specific structure causing your pain, throughout the relevant region of the spine?

Not every PRP spine injection reaches the same anatomy. An injection into the ligaments behind the lumbar spine is different from an injection into a facet joint. Neither is equivalent to a fluoroscopically guided epidural injection directed toward an irritated nerve root.

These procedures have different targets, different risk profiles, and different levels of supporting evidence.

The distinction matters because the source of your symptoms may not be where you feel the pain.

At Regen Experts in Dallas and Plano, my approach begins with identifying the likely pain generator. Only then do I consider whether an intervention is appropriate and, if so, which anatomical target and treatment approach make sense.



Why do some PRP physicians treat only the lumbar spine?


Some physicians providing orthobiologic spine care limit their procedures to the lumbar spine, sacroiliac region, or posterior spinal structures.

There can be legitimate reasons for this.

The cervical, thoracic, lumbar, and sacral regions differ in their anatomy, surrounding blood vessels, neurological structures, and procedural risks.

The spinal cord typically terminates around the L1–L2 vertebral level in adults, although there is anatomical variation. Above that level, the spinal cord occupies the spinal canal. Below it, the lumbar and sacral nerve roots continue as the cauda equina.

That difference is important, but it does not make lower lumbar interventions risk-free. Serious neurological complications, including vascular injury, can occur with lumbar transforaminal injections as well.

Some physicians appropriately restrict their procedural scope according to their training, experience, and assessment of risk.

The more useful question is not whether a physician performs every possible spine injection.

It is whether the physician can identify the likely source of your pain, explain which structures they can safely access, recognize the limits of their practice, and refer you when another approach is more appropriate.


PRP spine injections Dallas: Does the injection reach the structure causing your pain?


This is where the discussion becomes more interesting.

Consider a patient who develops back pain after sitting, with pain extending into the anterior thigh.

The MRI shows several findings:

  • Degenerative changes in the lumbar discs.

  • Facet joint arthritis.

  • Foraminal narrowing near an upper lumbar nerve root.

  • Changes involving supporting ligaments.

Which finding explains the symptoms?

Possibly one. Possibly several. And some may be incidental.

An MRI is important, but it cannot determine the source of pain by itself.

I want to know what provokes the symptoms, whether there are neurological findings, whether the pain distribution is anatomically consistent, and how the imaging correlates with the examination.

In some cases, a diagnostic procedure may help clarify the suspected pain generator.

If the clinical findings point toward irritation of a nerve root within or near the neural foramen, placing PRP into the posterior lumbar ligaments does not directly address that same target.

Likewise, a facet injection may be reasonable for appropriately selected facet-mediated pain, but it should not be presented as equivalent to treating a compressed or irritated nerve root.

The injection must be matched to the diagnosis.


What is the difference between ultrasound-guided and fluoroscopy-guided spine injections?


Ultrasound and fluoroscopy are both valuable imaging technologies. Their strengths depend on the structure being evaluated and the procedure being performed.

Ultrasound can provide real-time imaging of muscles, tendons, ligaments, certain joints, and other accessible soft tissues. Dynamic ultrasound can also reveal findings that static imaging may not show.

However, bone limits the ultrasound beam. Deep spinal targets and certain epidural or foraminal procedures may be difficult to visualize directly with ultrasound alone.

Fluoroscopy provides real-time X-ray guidance. When appropriate, contrast can help demonstrate needle-tip location and injectate distribution.

For many spinal epidural interventions, established safety recommendations emphasize fluoroscopic imaging, appropriate contrast use, and techniques intended to reduce the risk of intravascular or other unintended injection. Imaging cannot eliminate all procedural risk.


I use these both of these technologies for different reasons.

The objective is not to select whichever imaging modality is most convenient. It is to choose an appropriate method for the anatomical target and the clinical question.


Does a caudal epidural injection reach an upper lumbar nerve root?


Sometimes a caudal injection can spread to upper lumbar levels. But that distribution is variable, and reaching a vertebral level is not necessarily the same as reliably delivering treatment to a particular symptomatic nerve root.

A caudal epidural injection enters through the sacral hiatus and delivers medication or another injectate into the epidural space.

The material may travel upward. The extent and pattern of spread depend on factors such as volume, anatomy, previous surgery, epidural adhesions, and the characteristics of the injectate.

In a fluoroscopic study of caudal epidural injections, contrast spread was predominantly within the middle and lower lumbar regions despite escalating injection volumes. This illustrates why cephalad distribution should not simply be assumed. The study evaluated conventional injectate and contrast, not orthobiologic effectiveness.


Now consider a patient whose findings suggest an L2 or L3 nerve-root problem.

Would a caudal injection be my first choice?

Not automatically.

I would want to understand whether the treatment could reach the relevant anatomy sufficiently and whether a more targeted approach would be appropriate and safe.

A transforaminal epidural technique can provide more localized access near the exiting nerve root and ventral epidural region. But that anatomical advantage must be weighed against procedural hazards, including vascular and neurological complications.

More targeted delivery is not a guarantee of better results.

For orthobiologic injections specifically, we do not yet have sufficiently strong comparative evidence to conclude that transforaminal administration consistently produces superior long-term outcomes compared with caudal administration.



Why does the cervical and thoracic spine require different expertise?


The cervical and thoracic regions present anatomical challenges that are not identical to those in the lower lumbar spine.

The spinal cord, segmental arteries, radicular vessels, and other critical structures influence procedural planning.

In the cervical spine, the proximity of the vertebral artery and vessels supplying the spinal cord can be particularly important. In the thoracic region, spinal cord blood supply and the adjacent pleura are additional considerations.

These differences affect decisions about needle trajectory, imaging, contrast, injectate, and whether a particular procedure should be attempted at all.

There is a substantial body of procedural safety literature addressing conventional spine interventions. Much less clinical evidence is available for cervical and thoracic orthobiologic epidural applications.

Experience in performing conventional image-guided procedures does not, by itself, establish the safety or effectiveness of applying an emerging biologic preparation at those locations.

That is why I distinguish my procedural training from the evidence supporting an individual treatment.

I have decades of experience evaluating complex spine conditions and performing image-guided interventions. My background includes training throughout the cervical, thoracic, lumbar, and sacral spine.

The value of that experience is not that I can offer a procedure in every region.

It is that I understand the anatomy, the potential pain generators, the technical options, and the circumstances in which a procedure should not be performed.



Is the PRP preparation itself important?


Yes. PRP is not one standardized product.

Different preparation systems produce different platelet concentrations, leukocyte concentrations, volumes, and other compositional characteristics.

Platelet-rich plasma, platelet lysate, and bone marrow concentrate should not be treated as interchangeable substances.

That distinction becomes particularly important when considering administration in or near sensitive neural structures.

The viscosity, cellular content, volume, inflammatory potential, sterility, and preparation method may all be relevant to safety and tolerability.

However, there is not enough high-quality comparative evidence to establish the safest or most effective orthobiologic formulation for every spinal target.

I am particularly cautious about assumptions that concentrated or cell-containing preparations can simply be injected into the epidural space using protocols borrowed from peripheral joint treatment.

There are theoretical concerns as well as known general epidural injection hazards. They should be evaluated separately rather than presented as established complications of every PRP preparation.

The formulation matters. So does the anatomy. And neither substitutes for evidence of clinical benefit.


What does the scientific evidence actually show about PRP for spine pain?


One of the important developments in spine medicine is a growing understanding that pain may involve more than one structure.

A spinal motion segment is not simply a disc between two vertebrae. It includes the disc, facet joints, supporting ligaments, muscles, and adjacent neural structures. These components interact mechanically, and abnormalities in one may affect the others.

This has led to increasing interest in what researchers call the functional spinal unit approach.

Rather than assuming that one injection into one structure will address every source of pain, this approach considers whether multiple structures may be contributing to the patient's symptoms.

That does not mean every structure should be injected.

It means every relevant structure deserves thoughtful evaluation.


What does the evidence show?


The American Society of Interventional Pain Physicians' 2025 guidelines found fair evidence for certain lumbar PRP applications, including intradiscal and epidural injections. Evidence for lumbar facet and sacroiliac applications remains more limited.

Research specifically evaluating combined, multitarget functional spinal unit injections is still preliminary. We do not yet have sufficient high-quality comparative trials to establish whether treating multiple structures produces better outcomes than carefully selected individual interventions.

A 2025 review titled Functional Spinal Unit Approach for Orthobiologic Injections for Low Back Pain discusses the biological and biomechanical rationale for evaluating the spinal unit as an interconnected system.

For me, the most important implication is diagnostic.

If a patient has disc degeneration, facet arthritis, ligament abnormalities, and nerve-root symptoms, I want to understand which findings are clinically relevant before selecting a treatment.

Sometimes one structure is primarily responsible.

Sometimes several may be contributing.

And sometimes the appropriate decision is not to inject at all.


The objective is not to perform more injections. It is to make better-informed treatment decisions.

Orthobiologic treatments remain an evolving area of medicine. Patient selection, procedural safety, treatment formulation, and long-term outcomes continue to require careful study.





When might a spine injection not be appropriate?


Sometimes, the most important decision is not which procedure to perform, but whether a procedure should be performed at all.

A patient may be better served by targeted rehabilitation, activity modification, medication when appropriate, or observation.

Another patient may have multiple pain generators requiring further diagnostic assessment before any intervention.

And some conditions warrant prompt surgical assessment.

Progressive neurological weakness, suspected cauda equina syndrome, significant spinal cord compression with myelopathy, infection, or other serious pathology should never be approached as routine candidates for elective orthobiologic treatment.

If surgery is the right answer, I want my patient to know that, too.



What should you ask before choosing a PRP spine physician?


Before scheduling a spine procedure, I would want you to understand:

  1. What anatomical structure is believed to be causing my pain?

  2. What findings from my history, examination, and imaging support that diagnosis?

  3. Does the proposed injection actually reach that structure?

  4. Which imaging technique will be used, and why?

  5. What is known about the evidence, risks, and regulatory status of the proposed injectate?

  6. What other treatment options are reasonable, including no injection?

  7. What happens if the procedure does not help?

These questions matter more than whether a clinic advertises the highest platelet concentration, the newest technology, or the largest number of regenerative procedures.



My approach to complex spine pain


When I evaluate a patient with spine pain, my first question is not where I can place an injection. It is which structure is responsible for the symptoms.

A patient may have facet-mediated pain, disc-related pain, nerve-root irritation, ligament injury, or several contributing conditions.

Those structures are not interchangeable, and neither are the procedures used to address them.

My training in Anesthesiology and Pain Medicine, together with decades of image-guided spine experience, allows me to evaluate problems throughout the cervical, thoracic, lumbar, and sacral regions.

That experience does not mean every patient needs an injection.

It means I can consider the relevant anatomy, potential risks, and reasonable treatment options before recommending one.

If a treatment is appropriate, I want to know precisely what we are treating and why. If the evidence or anatomy does not support a particular intervention, that is equally important to explain.

My objective is to help patients make informed decisions about preserving function and remaining active, without overlooking the circumstances in which conventional treatment or surgery is the better choice.



Considering PRP or another nonsurgical option for spine pain in Dallas or Plano?


If you have persistent neck or back pain, have been offered an injection that you do not fully understand, or want a detailed evaluation before considering surgery, Regen Experts provides physician-led assessment of complex spine conditions.

A consultation with Deborah Westergaard, M.D. can help determine the likely pain generator, review your imaging and examination findings, and identify reasonable treatment options.

An evaluation does not guarantee eligibility for PRP, bone marrow concentrate, or another procedure. Orthobiologic outcomes vary, evidence for many spinal applications remains limited, and treatment may not be covered by insurance.



Frequently Asked Questions


Can PRP injections treat the entire spine?

PRP-based interventions have been studied primarily in the lumbar spine. Although image-guided procedures can access structures in different spinal regions, evidence for cervical and thoracic orthobiologic applications is more limited. Candidacy depends on diagnosis, anatomy, procedural risk, and available evidence.


Are fluoroscopy-guided PRP injections better than ultrasound-guided injections?

Not universally. Fluoroscopy and ultrasound visualize different structures and serve different purposes. The best guidance method depends on the intended target. Fluoroscopy with contrast is important for many epidural procedures, but better visualization alone does not establish the efficacy of PRP.


Can a caudal epidural injection reach an L2 or L3 nerve root?

It may, but upper lumbar spread is variable and should not be assumed. A targeted transforaminal approach may provide more localized delivery near a nerve root, although it has its own risks and has not been proven superior for every orthobiologic application.


Is PRP effective for lumbar degenerative disc disease?

Some clinical studies have reported improvements in pain or function following intradiscal PRP, but the evidence remains limited. The 2025 ASIPP guidelines classified lumbar intradiscal PRP evidence as Level III, or fair. Results vary and structural disc regeneration has not been reliably established in humans.


What qualifications should I look for in a spine injection physician?

Look for relevant specialty training, experience with the specific anatomical target and procedure, appropriate imaging guidance, knowledge of procedural safety, and the ability to distinguish when an injection is not indicated. Board certification and fellowship training are important qualifications to investigate, but should be evaluated alongside individual procedural experience.


Can orthobiologic injections help me avoid spine surgery?

Some selected patients may have reasonable nonsurgical options. However, the evidence does not establish that PRP or bone marrow concentrate reliably prevents the need for spine surgery. Progressive neurological deficits, myelopathy, and certain structural conditions may warrant surgical evaluation.



Comments


COSTS & COVERAGE

What will treatment cost?

A joint is a working system of cartilage, bone, ligaments, tendons, and supporting muscles. Your plan may include an injection into the joint space and targeted treatment of other tissues contributing to pain or dysfunction. Dr. Westergaard selects the orthobiologic, concentration, and dose for each appropriate target, considering the tissue involved, severity of the condition, your age, and clinical findings. Your estimate reflects the scope of your recommended care. Your evaluation is billed separately, and you receive an individualized written procedure estimate before scheduling.

​

​Orthobiologic procedures are generally not covered by traditional insurance. Regenexx employer benefits may cover eligible treatment, depending on your plan. CareCredit is available, subject to credit approval.

bottom of page